Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
|
10213212 |
1999 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
VEGF-A expression correlates with SCCRO expression in these primary human lung squamous cell carcinomas and is a predictor of clinical behavior.
|
15123463 |
2004 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
VEGF is also a promoter of angiogenesis in many tumour types, and has therefore been subject to numerous studies in oral dysplasia and squamous cell carcinomas.
|
16144770 |
2006 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Vascular endothelial growth factor (VEGF) protein expression was significantly increased in squamous cell carcinoma (SCC) samples from EP2 TG mice compared that of WT mice.
|
16607275 |
2006 |
Squamous cell carcinoma
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma.
|
18299215 |
2008 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
VEGF-A expression showed a correlation to histological type with increased expression in adenocarcinomas as compared to squamous cell carcinomas.
|
19324448 |
2009 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
VEGF and VEGFRs expression in oral squamous cell carcinoma.
|
19942948 |
2009 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
VEGF expression was positively associated with the MVD count of hypopharyngeal squamous cell carcinomas (r = 0.582, P = 0.000); however, integrin β1 was not associated with VEGF or MVD (P > 0.05).
|
25158264 |
2014 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
VEGF PI values were higher in pT1, pT2 then in pT3 and in the pN0 SCC, but without statistically significant differences.
|
28523303 |
2017 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
VEGF was expressed in 50% of the squamous cell carcinomas (SCC) and carcinoids but none of the others. p53 mutations occurred in 14 tumours (52%), and K-ras mutations were found in two adenocarcinomas and one SCC; there was no correlation between the mutations and VEGF expression.
|
9683299 |
1998 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
A high expression of VEGF (> or = 25% of cells) was observed in 75% and 73.34% of squamous cell carcinomas and adenocarcinomas, respectively, and in all cases of large cell carcinomas.
|
14981918 |
2004 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Adenocarcinomas showed significantly higher VEGF mRNA expression and a higher protein staining score than squamous-cell carcinomas.
|
11102890 |
2000 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Adenocarcinomas showed significantly higher staining scores of both VEGF and αSMA than squamous cell carcinomas did.
|
29970531 |
2018 |
Squamous cell carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients.
|
22818823 |
2012 |
Squamous cell carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Associations between single-nucleotide polymorphisms of the VEGF gene and long-term prognosis of oral squamous cell carcinoma.
|
23227881 |
2013 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Combined Analysis of Vascular Endothelial Growth Factor Expression with Cyclooxygenase-2 and Mast Cell Density in Oral Squamous Cell Carcinoma.
|
27577989 |
2017 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Comparison of immunohistochemical expression of vascular endothelial growth factor and CD105 in oral squamous cell carcinoma: Its correlation with prognosis.
|
29516931 |
2018 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma.
|
12883661 |
2004 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence.
|
17511025 |
2007 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Elevated VEGFA mRNA levels in oral squamous cell carcinomas and tumor margins: a preliminary study.
|
26861159 |
2016 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status.
|
10023341 |
1998 |
Squamous cell carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Expression of vascular endothelial growth factor (VEGF) in patients with oral squamous cell carcinoma and its clinical significance.
|
24833243 |
2014 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Expression of BDNF, TrkB, VEGF and CD105 is associated with pelvic lymph node metastasis and prognosis in IB2-stage squamous cell carcinoma.
|
31777532 |
2019 |
Squamous cell carcinoma
|
0.400 |
Biomarker
|
disease |
LHGDN |
Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
|
15254682 |
2004 |
Squamous cell carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
For the VEGF -2578C/A polymorphism, the combined results showed that there exist highly significant risk factors for individuals carrying the A allele resulting in lung cancer, and the magnitude of this effect was similar in smoker patients and squamous cell carcinoma (SCC) patients.
|
23982876 |
2014 |